Straight-Chain Naltrexone Ester Prodrugs: Diffusion and Concurrent Esterase Biotransformation in Human Skin
- 1 December 2002
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 91 (12) , 2571-2578
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Advances in development of medications for alcoholism treatmentPsychopharmacology, 1998
- Naltrexone and Alcohol DependenceArchives of General Psychiatry, 1997
- Experience of a "slip" among alcoholics treated with naltrexone or placeboAmerican Journal of Psychiatry, 1996
- Implication of the endogenous opioid system in excessive ethanol consumptionAlcohol, 1996
- Naltrexone and Coping Skills Therapy for Alcohol DependenceArchives of General Psychiatry, 1992
- Naltrexone in the Treatment of Alcohol DependenceArchives of General Psychiatry, 1992
- Maintenance of skin viability during in vitro percutaneous absorption/metabolism studiesToxicology and Applied Pharmacology, 1989
- Membrane-moderated controlled releaseMathematical Biosciences, 1981
- Physical Model Evaluation of Topical Prodrug Delivery—simultaneous Transport and Bioconversion of vidarabine-5′-valerate I: Physical Model DevelopmentJournal of Pharmaceutical Sciences, 1979
- Skin as an Active Metabolizing Barrier I: Theoretical Analysis of Topical BioavailabilityJournal of Pharmaceutical Sciences, 1977